• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ricoh buys Lanier, voice line goes to Platinum

Article

Ricoh and Lanier Worldwide have signed a definitive merger agreement, unanimously approved by Lanier's board, under which Ricoh will make a cash tender offer of $3 per share for all outstanding shares of Lanier common stock. However, Lanier's

Ricoh and Lanier Worldwide have signed a definitive merger agreement, unanimously approved by Lanier's board, under which Ricoh will make a cash tender offer of $3 per share for all outstanding shares of Lanier common stock. However, Lanier's voice products are not directly part of the deal. The merger with Ricoh is subject to regulatory approval and contingent on the sale of Lanier's voice business to Platinum Equity Holdings, a privately held firm specializing in acquiring and operating high-tech firms. The new voice products company, to be known as Lanier Health Care, has approximately 500 employees. Lanier should complete the transfer of its voice business within 30 days. Platinum projects sales in excess of $120 million for the 2001 fiscal year for Lanier Health Care.


© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 3.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.